MTDH and hepatocellular carcinoma: While very little to no AEG-1 immunostaining was detected in the normal liver samples, 93.58% of HCC samples showed variable AEG-1 levels which progressively increased with the stages I-IV and from well-differentiated to poorly differentiated (p < 0.0001) [13].